Semax + Selank Nasal Spray — 10 mL | 10 mg + 10 mg | Research Use Only

Description

Semax + Selank is a dual-peptide research formulation combining two synthetic peptides that have been independently studied in laboratory and preclinical models involving cognitive signaling, stress-response pathways, neuroplasticity, neurotrophic mechanisms, and neuroimmune activity.

This research formulation contains 10 mg Semax + 10 mg Selank in a 10 mL nasal spray format designed for controlled laboratory investigations involving peptide stability, neurological signaling, and cognitive research models.

For laboratory research use only. Not for human or animal consumption.

OVERVIEW

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–7) and has been investigated in research models involving neurotrophic signaling, neuronal protection, memory-related pathways, and cellular responses to neurological stress.

Selank is a synthetic peptide derived from the naturally occurring immunomodulatory peptide tuftsin. Research involving Selank has examined its interaction with neurological signaling systems, stress-response mechanisms, neuroimmune pathways, and gene-expression activity.

Together, Semax and Selank provide researchers with a combined peptide formulation for investigating complementary neurological and cognitive signaling pathways within controlled research environments.

Their distinct peptide structures and research profiles have contributed to continued scientific interest in areas involving neurobiology, cognitive function, stress-response pathways, and peptide-mediated cellular signaling.

PRODUCT SPECIFICATIONS

Compound: Semax + Selank
Semax Quantity: 10 mg
Selank Quantity: 10 mg
Total Peptide Content: 20 mg
Volume: 10 mL
Form: Research nasal spray solution
Format: Multi-peptide formulation
Storage: 2–8°C recommended; protect from light
Purity: Refer to current batch Certificate of Analysis

RESEARCH APPLICATIONS

• Cognitive signaling research
• Neuroplasticity pathway studies
• Neurotrophic signaling research
• Stress-response pathway models
• Neurological cellular-response research
• Neuroimmune signaling investigations
• Gene-expression studies
• Peptide stability research
• Comparative peptide signaling studies
• Neurological research models

RESEARCH BACKGROUND

Semax has been examined in experimental research involving neurotrophic factors, neuronal signaling, oxidative stress responses, neurological injury models, and memory-associated biological pathways.

Research involving Selank has explored neurological and neuroimmune signaling, gene-expression changes, stress-response pathways, and interactions with systems associated with inhibitory neurotransmission.

Because the two peptides have distinct structures and research histories, combined formulations may be useful for laboratory investigations exploring multiple peptide-mediated pathways within a single experimental framework.

Research involving Semax and Selank remains an active area of scientific investigation. Findings from laboratory or preclinical studies should not be interpreted as evidence of approved therapeutic use or clinical efficacy.

RESEARCH USE ONLY

This product is intended strictly for laboratory research purposes.

Not for human consumption. Not for veterinary use. Not for therapeutic or diagnostic applications. Not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Use is limited to qualified professionals conducting controlled laboratory research.